Indonesia’s COVID-19 Show
In a scene that could pass for street‑level drama, the country’s maritime minister, Luhut Pandjaitan, pitched herbal mangosteen juice as a cure for the coronavirus just last week. It’s the latest chapter in a series of unconventional remedies that have been floating around the president’s cabinet for the past half year.
The “Mom‑in‑a‑Hat” Palate:
- Prayer circles that turn the nation into a giant rosary.
- Rice wrapped in banana leaves—because “nature is safe” is the mantra.
- Eucalyptus necklaces that pretend to ward off the virus.
- Now, mangosteen juice for a chilled stance against the foe.
Why would you trust a mockumentary of a fruit drink over a vaccine, you ask? The answer lies in Indonesia’s dry testing stats and minimal contact tracing, coupled with stubborn refusals to lock down even as infections rocketed.
Numbers: Where They Stack
Officially, the nation reports 6,346 COVID‑19 deaths, the highest toll in Southeast Asia. If you add those who slipped away with influenza‑like symptoms but never got tested, the death count three‑folds. The situation looks nothing like a conquered beast.
The infection velocity? A staggering 17% positive rate among those tested, which climbs to almost 25% outside Jakarta. WHO flags anything above 5% as a sign that the outbreak is still breathing.
Complicating the story is a quote from Prijo Sidipratomo, dean of the Faculty of Medicine at the National Veterans Development University:
“We’re basically chasing herd immunity. Let’s just dig a bunch of graves, and we’re good.”
Herd immunity: a scenario where a mass of people get the virus, warriors win, and the rest of the populace gets a free election in immunity. Sounds high‑jazz, but the numbers say otherwise.
Policy Brains: The Responders
Government spokesman Wiku Adisasmito stayed tight‑lipped, replying only that the infection news is a “warning” and that Indonesia’s “per‑capita positive rate” is lower than most nations. Meanwhile, President Joko Widodo’s office didn’t answer any of Reuters’ questions.
Facts vs. Figures
Indonesia’s raw cases: 144,945 out of a 270‑million population. By comparison, the United States, Brazil, and India are all flying in the millions. Even the Philippines—half the population of Indonesia—has stepped ahead. But we’re not seeing the raw truth: India and the Philippines test four times more per capita, while the U.S. is testing 30 times more.
A nonprofit, Oxford‑based research group (Our World in Data) ranked Indonesia 83rd out of 86 for overall tests per person. That’s a pretty hot flat‑iron.
Looking Ahead: Epidemiologists Take the Stage
University of Indonesia epidemiologist Iwan Ariawan warned that the nation has not hit its peak yet. He predicts a possible peak in October, with the pandemic possibly not ending this calendar year.
“Right now we can’t say it’s under control.”
In short, the story is a bit like a superhero movie where the hero never leaves the kitchen. Indonesia is still fighting its own story and we’re all watching on the sidelines—preferably with a mug of that mangosteen juice.
‘PURE NONSENSE’
Indonesia’s COVID‑19 Testing Tangle: A Story of Slow Starts and Quick‑Fix Fumbles
What Happens When the Government Lags
At the beginning of the pandemic, the Indonesian government was less nimble than a sloth in a rainstorm. Even though neighboring countries were deep‑in‑the‑red, and the country had 3,000 PCR kits ready by early February, fewer than 160 tests were actually run by March 2.
The “We’re Not Wilding Out” Approach
On March 13, President Widodo claimed the government was hiding data to avoid a panic parade. Inside the first two weeks of March, officials admitted they were keeping half the daily infections under wraps. Those who saw the real numbers were later barred from the raw data—no “open data” party here.
Rapid Tests: Quick but Messy
- Rapid antibody tests were found to be less reliable than PCR swabs. They’re like a cheap watch: good for telling the time, not for measuring your heart rate.
- Widodo’s push for rapid tests drained resources from PCR testing, according to three lab managers.
- Importers—including state enterprises and private firms—charged up to 1,000,000 rupiah (about US$92) for a test that cost just 50,000 rupiah to run.
- By mid‑April, rapid tests in West Java, Bali and Yogyakarta were producing a jumble of false negatives and positives.
- Rapid testing was still widely used, and it wasn’t until July that imports were halted and a price cap was set at 150,000 rupiah.
“What’s the Point of a Positive?”, Says Commissioner Lie
Commissioner Alvin Lie slammed the idea that a rapid test gives you a 14‑day “free pass” from the virus. “That’s pure nonsense,” he said. “It only tells you so far about the moment you took the sample.”
What About the President?
Adisasmito didn’t comment on whether the president’s rapid‑testing call knocked the wider testing effort. He did admit that rapid tests have a role where PCR capacity is limited—like screening travellers—yet didn’t answer questions about the big profits piled up by companies.
Testing in Numbers: Much More Fast, Much Less Reliable
While the Central Government won’t disclose national rapid‑testing totals, West Java’s data shows it has run 50 % more rapid tests than PCR tests. The country now operates 269 labs equipped with PCR machines, yet labs struggle to keep up.
Labs Are Overworked
Occasional labs can test over 30,000 people per day, more than twice the recent monthly average of 12,650. Yet shortages of staff and reagents keep labs from hitting this potential. Five lab managers said mismanagement caused the shortfalls—they didn’t have enough time or the right chemicals to run all samples.
What’s the Human Toll?
The number of suspected cases—people with COVID‑19 symptoms who haven’t been tested—has doubled in the last month to about 79,000. That’s a big number of folks walking around feeling “insecure” while waiting for a test.
Bottom Line: Testing is a Long‑Distance Relay
Indonesia’s testing trajectory shows a government caught in the same snafu many countries faced: slow roll‑out, temptation for “quick fixes,” and a lack of resource management. The lesson? Even if you’re quick with a rapid test, it may not do the job—unless you have the right support, enough labs, and very real data.
If the country can finally reconcile those ingredients, the future might just see a healthier, more resilient public health system—and maybe a few less punchlines about “free passes.”
MINIMAL CONTACT TRACING
Indonesia’s Contact‑Tracing Slip‑Up: A Cautionary Tale
The pandemic’s survival kit has two key ingredients: mass PCR tests and swift results. The Indonesian health ministry nailed this in its July 13 guidelines, calling contact tracing the silver bullet that can break the virus’s chain of transmission.
On the Ground: A Rough Patch
Reuters talked to 12 health workers from across the archipelago, and they’re not pulling any punches about how things look in practice.
- Rahmat Januar Nor, a health officer in Banjarmasin (the delta city of Borneo), described the influx of new case data as a chaotic mess – names half‑gone, dead phone numbers, and addresses that no longer match the people. “We’re chasing ghosts,” he said.
- “We asked the village leaders for help,” Nor added, “but we usually missed the contacts.”
- Even when contacts were finally reached, a lot of them declined testing, fearing they’d lose jobs or be shunned. That’s the reality of a community where health carries a stigma.
The Numbers: Low‑Key Tracking
Unpublished stats from the country’s COVID‑19 Task Force, crossed by Reuters, show that only 53.7% of confirmed or suspected cases received any contact tracing by early June.
While the official target is 30 people per positive case, that figure is still short when stacked against regional leaders.
- South Korea reported tracing and testing nearly 8,000 contacts after a nightclub incident last May, showcasing a stark contrast.
- The World Health Organization recommends at least 20 contacts traced per case, but Indonesian provincial officials and Reuters data put them at just about 2 per case.
Regional Breakdown
- Jakarta – the epicenter of Indonesia’s early outbreak – averages fewer than 2 contacts per confirmed or suspected case in July.
- East Java – another hotspot – sees tracing rates of 2.8 contacts per confirmed/suspected patient according to researchers from Airlangga University.
Steps Forward
A spokesperson from WHO noted that Indonesia started aligning with their tracing recommendations mid‑July. The road ahead is challenging, but catching that ‘when‑you‑need‑to‑know’ moment could still turn the tide.
‘ALWAYS ON THE FIRST WAVE’
Indonesia Skips Lockdown: Balancing Economy and Health
Why the Decision?
According to government advisers, the choice to skip full lockdowns stemmed from two big concerns: economic survival and social stability.
Persuaded that a hard stop could spark unrest, officials opted for targeted measures instead of a blanket shutdown.
What We’re Asked to Do
- Wear masks while working, travelling or socialising.
- Wash hands regularly—no excuses!
- Keep a safe distance; buddy system with a 6‑foot bubble.
Economic Upside
With a 5.3% contraction in Q2 2020, Indonesia outperformed many neighbors—less of a free‑fall, more of a tumbledown.
Public opinion is kind of happy: people love the less disruptive approach.
Health System Hurdles
Experts warn that the relaxed approach might cost the country more in the long run.
Dr. Bambang Pujo—an anaesthetist turned marathon‑running hero at Surabaya’s Covid‑19 hub—recounts the brutal reality:
“Mortality rates in our ward are a nightmare—between 50% and 80%. There aren’t enough beds. Working ten hours in a hazmat suit feels like running a marathon twice. We’re playing God, hoping we don’t slip. If we do, we need compassion and forgiveness.”
Bed Capacity Snap‑Shot
Indonesia has just 2.5 ICU beds per 100,000 people, far below India’s 6.9 per 100k (per a Columbia‑backed study).
We’re not just ready; we’re still on the first wave while other countries brace for the second.
Looking Ahead
- Health infrastructure improvements are ongoing.
- Government remains vigilant, turning every data point into a lesson.
Keep Updated
Stay tuned for the latest on the spread of COVID‑19.
Coronavirus | COVID‑19
